Justice Department Inspector General to Investigate DEA Program Linked to Massacres in Mexico

Justice Department Inspector General to Investigate DEA Program Linked to Massacres in Mexico

Justice Department Inspector General Michael Horowitz said his office would examine the program flagged as “high risk” to ensure adequate internal controls are in place. The Justice Department’s inspector general announced on Tuesday that his office would investigate a Drug Enforcement Administration program linked to violent drug cartel attacks in Mexico that have left dozens, possibly hundreds, of people dead or missing.

In a letter to senior congressional Democrats, Inspector General Michael E. Horowitz said that an internal review had flagged the DEA’s Sensitive Investigative Units program as “an area of high risk.” His office, he wrote, would examine the drug agency’s management of the program and whether internal controls are in place to ensure that “DEA operations, information and personnel are protected from compromise.”

Under the program, the DEA vets and trains teams of Mexican federal police officers, known as SIUs, that conduct DEA-led operations in Mexico. Last year, ProPublica and National Geographic reported that at least two such operations were compromised and triggered deadly spasms of violence, including one that occurred less than an hour’s drive away from the Mexican border with Texas. A June 2017 story revealed that an attack on the small ranching town of Allende in the Mexican state of Coahuila in 2011 was unleashed after sensitive information obtained during a DEA operation wound up in the hands of cartel leaders, who ordered a wave of retaliation against suspected traitors.

A second story in December investigated a 2010 cartel attack on a Holiday Inn in Monterrey, Mexico, […]

THE POWER OF STEM CELLS & EXOSOMES
Scientists have recently developed advanced protocols harnessing the power of exosomes to create a new class of therapeutics to improve the effectiveness of stem cell therapy. In particular, they have developed new protocols for neurological diseases such as Alzheimer´s, Parkinson´s, Autism and Multiple Sclerosis. Read More